235 related articles for article (PubMed ID: 10447777)
1. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease.
Meager A; Wadhwa M; Bird C; Dilger P; Thorpe R; Newsom-Davis J; Willcox N
Immunology; 1999 Jul; 97(3):526-32. PubMed ID: 10447777
[TBL] [Abstract][Full Text] [Related]
2. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
[TBL] [Abstract][Full Text] [Related]
3. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.
Rosen LB; Rocha Pereira N; Figueiredo C; Fiske LC; Ressner RA; Hong JC; Gregg KS; Henry TL; Pak KJ; Baumgarten KL; Seoane L; Garcia-Diaz J; Olivier KN; Zelazny AM; Holland SM; Browne SK
Clin Infect Dis; 2015 Apr; 60(7):1017-25. PubMed ID: 25472947
[TBL] [Abstract][Full Text] [Related]
4. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
Hellmich B; Ciaglo A; Schatz H; Coakley G
Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
[TBL] [Abstract][Full Text] [Related]
7. Standardized serum GM-CSF autoantibody testing for the routine clinical diagnosis of autoimmune pulmonary alveolar proteinosis.
Uchida K; Nakata K; Carey B; Chalk C; Suzuki T; Sakagami T; Koch DE; Stevens C; Inoue Y; Yamada Y; Trapnell BC
J Immunol Methods; 2014 Jan; 402(1-2):57-70. PubMed ID: 24275678
[TBL] [Abstract][Full Text] [Related]
8. Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy.
Wadhwa M; Bird C; Fagerberg J; Gaines-Das R; Ragnhammar P; Mellstedt H; Thorpe R
Clin Exp Immunol; 1996 May; 104(2):351-8. PubMed ID: 8625532
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
Uchida K; Nakata K; Suzuki T; Luisetti M; Watanabe M; Koch DE; Stevens CA; Beck DC; Denson LA; Carey BC; Keicho N; Krischer JP; Yamada Y; Trapnell BC
Blood; 2009 Mar; 113(11):2547-56. PubMed ID: 19282464
[TBL] [Abstract][Full Text] [Related]
10. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.
Svenson M; Hansen MB; Ross C; Diamant M; Rieneck K; Nielsen H; Bendtzen K
Blood; 1998 Mar; 91(6):2054-61. PubMed ID: 9490690
[TBL] [Abstract][Full Text] [Related]
11. The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review.
Ataya A; Knight V; Carey BC; Lee E; Tarling EJ; Wang T
Front Immunol; 2021; 12():752856. PubMed ID: 34880857
[TBL] [Abstract][Full Text] [Related]
12. Familial Association of Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Inflammatory Bowel Disease.
Wright SS; Trauernicht A; Bonkowski E; McCall CA; Maier EA; Bezold R; Lake K; Chalk C; Trapnell BC; Kim MO; Kugathasan S; Denson LA
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):767-772. PubMed ID: 29216019
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
Xu KF; Chen Y; Guo ZJ; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
[TBL] [Abstract][Full Text] [Related]
14. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
[TBL] [Abstract][Full Text] [Related]
15. A cell free assay system estimating the neutralizing capacity of GM-CSF antibody using recombinant soluble GM-CSF receptor.
Urano S; Tazawa R; Nei T; Motoi N; Watanabe M; Igarashi T; Tomita M; Nakata K
J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730949
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.
Kitamura T; Tanaka N; Watanabe J; Uchida ; Kanegasaki S; Yamada Y; Nakata K
J Exp Med; 1999 Sep; 190(6):875-80. PubMed ID: 10499925
[TBL] [Abstract][Full Text] [Related]
17. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of development and characteristics of antibodies induced in cancer patients against yeast expressed rDNA derived granulocyte macrophage colony stimulating factor (GM-CSF).
Rini B; Wadhwa M; Bird C; Small E; Gaines-Das R; Thorpe R
Cytokine; 2005 Jan; 29(2):56-66. PubMed ID: 15598439
[TBL] [Abstract][Full Text] [Related]
19. Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients.
Ragnhammar P; Friesen HJ; Frödin JE; Lefvert AK; Hassan M; Osterborg A; Mellstedt H
Blood; 1994 Dec; 84(12):4078-87. PubMed ID: 7994026
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.
Wadhwa M; Meager A; Dilger P; Bird C; Dolman C; Das RG; Thorpe R
Immunology; 2000 Jan; 99(1):113-23. PubMed ID: 10651949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
